<DOC>
	<DOC>NCT00035503</DOC>
	<brief_summary>The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.</brief_summary>
	<brief_title>Multicenter Trial For Patients With Acute Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Must have active confirmed Crohn's disease with CDAI &gt; 220 and &lt; 400. Otherwise healthy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>